Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
ANI Pharmaceuticals Inc (NASDAQ: ANIP) closed the day trading at $84.55 down -3.12% from the previous closing price of $87.27. In other words, the price has decreased by -$3.12 from its previous closing price. On the day, 0.59 million shares were traded. ANIP stock price reached its highest trading level at $87.89 during the session, while it also had its lowest trading level at $84.09.
Ratios:
For a better understanding of ANIP, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.15. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.58. In the meantime, Its Debt-to-Equity ratio is 1.25 whereas as Long-Term Debt/Eq ratio is at 1.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on July 10, 2025, initiated with a Buy rating and assigned the stock a target price of $84.
On March 14, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $80.
On March 12, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $85.JP Morgan initiated its Overweight rating on March 12, 2025, with a $85 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 13 ’25 when PATRICK WALSH bought 8,643 shares for $86.88 per share.
Cook Meredith sold 400 shares of ANIP for $36,036 on Oct 13 ’25. The SR. VP, GENERAL COUNSEL & SEC. now owns 75,674 shares after completing the transaction at $90.09 per share. On Sep 19 ’25, another insider, Davis Krista, who serves as the SVP, CHIEF HR OFFICER of the company, sold 1,000 shares for $98.04 each. As a result, the insider received 98,040 and left with 60,186 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANIP now has a Market Capitalization of 1898838144 and an Enterprise Value of 2127558400. As of this moment, ANI’s Price-to-Earnings (P/E) ratio for their current fiscal year is 51.85, and their Forward P/E ratio for the next fiscal year is 10.10. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.30 while its Price-to-Book (P/B) ratio in mrq is 3.76. Its current Enterprise Value per Revenue stands at 2.573 whereas that against EBITDA is 14.666.
Stock Price History:
The Beta on a monthly basis for ANIP is 0.48, which has changed by 0.49434423 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, ANIP has reached a high of $99.50, while it has fallen to a 52-week low of $52.50. The 50-Day Moving Average of the stock is -9.08%, while the 200-Day Moving Average is calculated to be 14.71%.
Shares Statistics:
Over the past 3-months, ANIP traded about 405.33K shares per day on average, while over the past 10 days, ANIP traded about 413530 shares per day. A total of 22.46M shares are outstanding, with a floating share count of 19.36M. Insiders hold about 13.86% of the company’s shares, while institutions hold 87.31% stake in the company. Shares short for ANIP as of 1761868800 were 2504638 with a Short Ratio of 6.18, compared to 1759190400 on 2333543. Therefore, it implies a Short% of Shares Outstanding of 2504638 and a Short% of Float of 13.889999999999999.
Earnings Estimates
Investors are keenly observing as 7.0 analysts analyze and rate. The current performance of ANI Pharmaceuticals Inc (ANIP) in the stock market.The consensus estimate for the next quarter is $1.73, with high estimates of $2.01 and low estimates of $1.44.
Analysts are recommending an EPS of between $7.62 and $7.21 for the fiscal current year, implying an average EPS of $7.5. EPS for the following year is $8.37, with 8.0 analysts recommending between $9.31 and $7.53.
Revenue Estimates
7 analysts predict $232.71M in revenue for. The current quarter. It ranges from a high estimate of $242.14M to a low estimate of $227.8M. As of. The current estimate, ANI Pharmaceuticals Inc’s year-ago sales were $190.57MFor the next quarter, 7 analysts are estimating revenue of $213.95M. There is a high estimate of $222.03M for the next quarter, whereas the lowest estimate is $205.2M.
A total of 8 analysts have provided revenue estimates for ANIP’s current fiscal year. The highest revenue estimate was $878.44M, while the lowest revenue estimate was $866M, resulting in an average revenue estimate of $869.57M. In the same quarter a year ago, actual revenue was $614.38MBased on 8 analysts’ estimates, the company’s revenue will be $954.76M in the next fiscal year. The high estimate is $1.01B and the low estimate is $913M.
